A citation-based method for searching scientific literature

György Szabó, Sándor Kolok, Zoltán Orgován, Mónika Vastag, Zoltán Béni, János Kóti, Katalin Sághy, György I Lévay, István Greiner, György M Keserű. Eur J Med Chem 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison.
David H Adams, Lu Zhang, Brian A Millen, Bruce J Kinon, Juan-Carlos Gomez. Schizophr Res Treatment 2014
46
100


Assessing nociceptive sensitivity in mouse models of inflammatory and neuropathic trigeminal pain.
Agnieszka Krzyzanowska, Silvia Pittolo, Marina Cabrerizo, Jorge Sánchez-López, Senthil Krishnasamy, César Venero, Carlos Avendaño. J Neurosci Methods 2011
39
100

The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2.
Pier L D'Alessandro, Corrado Corti, Adelheid Roth, Annarosa Ugolini, Anna Sava, Dino Montanari, Federica Bianchi, Stephen L Garland, Ben Powney, Emma L Koppe,[...]. Bioorg Med Chem Lett 2010
15
100

Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?
Darryle D Schoepp DD, Gerard J Marek. Curr Drug Targets CNS Neurol Disord 2002
69
100


Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depression.
Justine M Kent, Ella Daly, Iva Kezic, Rosanne Lane, Pilar Lim, Heidi De Smedt, Peter De Boer, Luc Van Nueten, Wayne C Drevets, Marc Ceusters. Prog Neuropsychopharmacol Biol Psychiatry 2016
34
100

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.
Sandeep T Patil, Lu Zhang, Ferenc Martenyi, Stephen L Lowe, Kimberley A Jackson, Boris V Andreev, Alla S Avedisova, Leonid M Bardenstein, Issak Y Gurovich, Margarita A Morozova,[...]. Nat Med 2007
791
100

1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis.
Lei Zhang, Michael A Brodney, John Candler, Angela C Doran, Allen J Duplantier, Ivan V Efremov, Edel Evrard, Kenneth Kraus, Alan H Ganong, Jessica A Haas,[...]. J Med Chem 2011
17
100

PHASE: a novel approach to pharmacophore modeling and 3D database searching.
Steven L Dixon, Alexander M Smondyrev, Shashidhar N Rao. Chem Biol Drug Des 2006
349
100



Metabotropic glutamate receptors and the control of chronic pain.
Santina Chiechio, Ferdinando Nicoletti. Curr Opin Pharmacol 2012
78
100



Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders,[...]. J Pharmacol Exp Ther 2013
51
100

Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats.
Rosa Maria A Simmons, Amy A Webster, Anshu B Kalra, Smriti Iyengar. Pharmacol Biochem Behav 2002
95
100

Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site.
Blake A Rowe, Hervé Schaffhauser, Sylvia Morales, Laura S Lubbers, Celine Bonnefous, Theodore M Kamenecka, Jeffrey McQuiston, Lorrie P Daggett. J Pharmacol Exp Ther 2008
39
100

Quantitative assessment of tactile allodynia in the rat paw.
S R Chaplan, F W Bach, J W Pogrel, J M Chung, T L Yaksh. J Neurosci Methods 1994
100

Fragment Based Optimization of Metabotropic Glutamate Receptor 2 (mGluR2) Positive Allosteric Modulators in the Absence of Structural Information.
György Szabó, György I Túrós, Sándor Kolok, Mónika Vastag, Zsuzsanna Sánta, Miklós Dékány, György I Lévay, István Greiner, Minami Natsumi, Watanabe Tatsuya,[...]. J Med Chem 2019
9
100

AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
Robert E Litman, Mark A Smith, James J Doherty, Alan Cross, Shane Raines, Lev Gertsik, Stephen R Zukin. Schizophr Res 2016
48
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.